Dr. Murat A. Anamur
Claim this profileLowell General Hospital
Studies Cancer
Studies Lung Cancer
10 reported clinical trials
27 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
p16 positive
2Lung Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Murat A. Anamur is currently running
Pembrolizumab + Gemcitabine
for Bladder Cancer
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding pembrolizumab to gemcitabine may delay the return of BCG-unresponsive bladder cancer for longer period compared to gemcitabine alone.
Recruiting1 award Phase 223 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
More about Murat A. Anamur
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Murat A. Anamur has experience with
- Cisplatin
- Gemcitabine Hydrochloride
- Pembrolizumab
- Nivolumab
- Carboplatin
- Radiation Therapy
Breakdown of trials Murat A. Anamur has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Murat A. Anamur specialize in?
Murat A. Anamur focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Murat A. Anamur currently recruiting for clinical trials?
Yes, Murat A. Anamur is currently recruiting for 2 clinical trials in Lowell Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Murat A. Anamur has studied deeply?
Yes, Murat A. Anamur has studied treatments such as Cisplatin, Gemcitabine Hydrochloride, Pembrolizumab.
What is the best way to schedule an appointment with Murat A. Anamur?
Apply for one of the trials that Murat A. Anamur is conducting.
What is the office address of Murat A. Anamur?
The office of Murat A. Anamur is located at: Lowell General Hospital, Lowell, Massachusetts 01854 United States. This is the address for their practice at the Lowell General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.